NOVO NORDISK A/S - Denmark 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:600-700
2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:700-800
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:900-1000
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:600-700
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Total Project Funding:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:800-900
Project Leadership Index:500-600
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:600-700
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 32
As coordinator: 0
As participant: 32
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 8.160.613 580.688 2
2022 0 7.518.062 424.250 1
2021 0 53.502.214 297.522 4
2020 0 42.532.244 300.000 5
2019 0 40.904.592 0 4
2018 0 25.821.795 290.082 5
2017 0 31.347.714 0 3
2016 0 26.949.452 580.164 3
2015 0 20.276.334 290.082 2
2012 0 8.316.954 912.873 2
2010 0 3.199.995 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
PFIZER LIMITED15
NOVARTIS PHARMA12
JANSSEN PHARMACEUTICA NV11
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD10
ELI LILLY AND COMPANY LIMITED9
KATHOLIEKE UNIVERSITEIT LEUVEN9
SANOFIAVENTIS9
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT8
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE7
UCB BIOPHARMA7
BAYER6
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG6
SANOFIAVENTIS DEUTSCHLAND6
UNIVERSITY OF COPENHAGEN6
UNIVERSITY OF DUNDEE6
UPPSALA UNIVERSITET6
F HOFFMANNLA ROCHE5
JDRF INTERNATIONAL5
MEDIZINISCHE UNIVERSITAT GRAZ5
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN5
REGION HOVEDSTADEN5
TAKEDA PHARMACEUTICALS INTERNATIONAL5
UNIVERSITAET ULM5
ABBVIE INC4
ACADEMISCH ZIEKENHUIS GRONINGEN4
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE4
FORUM DES PATIENTS EUROPEENS4
H LUNDBECK AS4
KING'S COLLEGE LONDON4
LUND UNIVERSITY4
MEDIZINISCHE UNIVERSITAET WIEN4
MERCK SHARP & DOHME CORP4
STICHTING KATHOLIEKE UNIVERSITEIT4
THE UNIVERSITY OF MANCHESTER4
THE UNIVERSITY OF SHEFFIELD4
UNIVERSITE DE LAUSANNE4
UNIVERSITY COLLEGE DUBLIN4
UNIVERSITY OF CAMBRIDGE4
ASTELLAS PHARMA EUROPE BV3
CONSIGLIO NAZIONALE DELLE RICERCHE3
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS3
KAROLINSKA INSTITUTE3
LEIDS UNIVERSITAIR MEDISCH CENTRUM3
LIPOTYPE3
LUNDS UNIVERSITET3
OSPEDALE PEDIATRICO BAMBINO GESU3
SIB INSTITUT SUISSE DE BIOINFORMATIQUE3
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM3
STICHTING VUMC3
TAKEDA DEVELOPMENT CENTRE EUROPE3
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA3
THE LEONA M AND HARRY B HELMSLEY CHARITABLE TRUST3
THE UNIVERSITY OF EXETER3
THE UNIVERSITY OF LIVERPOOL3
UNIVERSITA DEGLI STUDI DI MILANO3
UNIVERSITA DEGLI STUDI DI PADOVA3
UNIVERSITA DEGLI STUDI DI SIENA3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITE LIBRE DE BRUXELLES3
UNIVERSITY OF HELSINKI3
UNIVERSITY OF TURKU3
UNIVERSITY OF WALES CARDIFF3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ACADEMISCH ZIEKENHUIS LEIDEN2
ALLERGAN LIMITED2
ANTAROS MEDICAL AB2
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
ASTRAZENECA2
BAYER PHARMA2
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM2
BRISTOLMYERS SQUIBB COMPANY CORP2
CENTRE HOSPITALIER DE LUXEMBOURG2
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE2
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
COVANCE LABORATORIES2
DANMARKS TEKNISKE UNIVERSITET2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
ELI LILLY AND COMPANY2
ELLEGAARD GOTTINGEN MINIPIGS AS2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
EUROPEAN AIDS TREATMENT GROUP EV2
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION2
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES2
FUJIFILM CELLULAR DYNAMICS INC2
FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA2
GOETEBORGS UNIVERSITET2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
HANNOVERSCHE KINDERHEILANSTALT2
INSTITUT DE RECHERCHES SERVIER2
INSTITUT PASTEUR2
ITASUOMEN YLIOPISTO2
KOBENHAVNS UNIVERSITET2

Constancy:

Total number of partners: 789
Partner loyalty:
Frequent Partner: (> 2 projects): 316
Rare Partner: 473
Frequent / Rare Partner Ratio: 0.67

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Real-world evidence for decisions in diabetes REDDIEparticipant4.788.83414
2023-01-01Development of a multifunctional biomaterial patch for buccal delivery of peptide-analogue treatments BUCCAL-PEPparticipant3.371.7797
2022-06-01Next generation toolbox for greener pharmaceuticals design & manufacturing towards reduced environmental impact ENVIROMEDparticipant7.518.06217
2021-10-01Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies SCREEN4CAREparticipant11.938.56937
2021-09-01BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe BEAMERparticipant5.948.90331
2021-02-01Central Repository for Digital Pathology BIGPICTUREparticipant32.319.82551
2021-01-01Surface Integrity for Micro/Nano Processing of Polymers: A European Research Training Network for High-Performance Medical Devices SIMPPER_MedDevparticipant3.294.9179
2020-11-01Accelerating Research & Development for Advanced Therapies ARDATparticipant11.773.00034
2020-06-01Stratification of Obesity Phenotypes to Optimize Future Therapy SOPHIAparticipant8.301.00036
2020-05-01Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA INNODIA HARVESTparticipant5.999.05541
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69430
2020-01-01Novel Strategies for Cell-based Neural Reconstruction NSC-Reconstructparticipant8.168.49513
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95337
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64818
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027
2018-09-01PET Imaging of Alpha-Synuclein Fibril Formation PET-AlphaSyparticipant4.100.37017
2018-09-01Ensuring the future of EUPATI beyond 2020 EFOEUPATIparticipant365.24312
2018-05-01Hypoglycaemia - REdefining SOLutions for better liVEs Hypo-RESOLVEparticipant13.450.05723
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93135
2018-01-01European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets UbiCODEparticipant3.407.19420
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2016-09-01Unraveling Principles of PDZ-mediated Cell Signaling PDZnetparticipant3.733.51510
2016-04-01Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881 RHAPSODYparticipant8.130.00027
2015-11-01Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797 INNODIAparticipant17.630.00036
2015-01-01Multi-Stimuli Responsive Molecular Systems and Materials ResMoSysparticipant2.646.3349
2012-09-01A Portable bihormonal Closed Loop for Diabetes PCDIABparticipant4.335.2847
2012-01-01European Training Network for Excellence in Molecular Imaging in Diabetes BetaTrainparticipant3.981.67010
2010-10-01Intelligent and Customized Tooling IC2participant3.199.99516

Alias institution names:

  • NOVO NORDISK